Company History

• 2021

  • - Patent Registration: US 11,166,898 B2. Institution : US Patent and Trademark Office. 'Human Growth Hormone and Spider Fiber Hybrid Protein(GS)'
  • - Korea Beauty Brand Grand Prize(Meconomynews)
  • - Patent Registration: IN 370583. Institution : India Patent and Trademark Office. 'Scorpion Hybrid Protein (TCT)'
  • - Patent Registration: JP 6806889. Institution: Japan Patent and Trademark Office. 'Anti-freezing Protein(Sea Raven) Hybrid Protein(EAFPSR)'
  • - NEXGEN Head Office relocated to Seoul (703,7F, 186, Gasan digital 1-ro, Geumcheon-gu, Seoul, Republic of Korea (08502)

• 2020

  • - Patent Registration : US 10,815,284 B2 Institution : US Patent and Trademark Office 'Anti-Freeze Protein (EAFPSR)'
  • - Patent Registration : JP 6770175 Institution : Japan Patent and Trademark Office 'Scorpion Hybrid Protein (TCT)'
  • - Patent Registration : US 10,745,451 B2 Institution : US Patent and Trademark Office 'Scorpion Hybrid Protein (TCT)'
  • - Recipient of the 2020 Certificate of Excellent Technology Institution : Korea Enterprise Data
  • - Patent Registration : 10-2099097 Institution : Korean Intellectual Property Office 'Cosmetic Composition Containing Tertiapin as an Active Ingredient'

• 2019

  • - Acquiring a smart plant level confirmation certificate (SBCR)
  • - European Patent and Trademark Office to register 'Spider-Venom Hybrid Protein (ESV)' patent (EP 3 339 319)
  • - U.S. Patent and Trademark Office registered ‘GFPEGF’ patent (US 10,411,632 B2)
  • - 2019 Participation in Intercham Exhibition
  • - Japan Patent and Trademark Office registered ‘Botulinum Hybrid Protein (BTALE) patent (JP 6592112)
  • - European Patent Office registers ‘Botulinum Hybrid Protein (BTALE) patent (EP 3 299 385 B1)
  • - NEXGEN Head Office relocated to Seoul (3F, Happyland, 66, digital-ro 31-gil, Guro-gu, Seoul, 08376, Seoul）
  • - 2019 Outstanding Patent Award (Korea Daily)
  • - US Patent Office Registered Patent for Bottle Hybrid Protein (US 10,266,817 B2)
  • - Patent registration of 'ESV' (JP 6472580)

• 2018

  • - KICPD, Winner of the 24th Best Brand & Package Design Awards 'Best Brand Planning Award'
  • - USPTO(US Patents and Trademark Office), 'Spider Venom Hybrid protein(ESV)' Patent Registered (US 10,125,181 B2)
  • - KMR, Manufacturing and Quality Management of Cosmetics Certification companies certified (ISO 22716:2007)
  • - SBCR, Quality Management System Certification (KS Q ISO 9001:2015 / ISO 9001:2015) Extended
  • - USPTO(US Patents and Trademark Office), SV82 Polypeptide use as Anti-Wrinkle and Elasticity Enhancing skin care Cosmetic Ingredients(US 9, 879, 060 B2)

• 2017

  • - Japanese Patent: SV82 Polypeptide use as Anti-Wrinkle and Elasticity Enhancing skin care Cosmetic Ingredients
  • - KIPO, 'Heat Shock Hybrid Protein (H10H20)' Patent Registered
  • - KIPO, 'Growth Factor Differented Hybrid Protein' Patent Registered
  • - KIPO, Heat Shock Hybrid Protein (GD11H10) Patent Registered
  • - KIPO, Heat Shock Hybrid Protein (H10H20) Patent Registered
  • - SBCR, Eco-Friendly Management Certification (KS I ISO 14001:2015 / ISO 14001:2015) Extended
  • - SBCR, Quality Management System Certification (KS Q ISO 9001:2015 / ISO 9001:2015) Extended
  • - Registered as a patent for 'Plant Sweet Protein-Heat Shock Protein (BRAZZEIN)'

• 2016

  • - SBCR, Environmental Management System companies certified (KS I ISO 14001:2015 / ISO 14001:2015)
  • - KIPO, 'Anti-Freeze Protein' Patent Registered (10-1678392)
  • - KIPO, 'Scorpion Toxin Hybrid Protein' Patent Registered (10-1678393)
  • - KIPO, 'Hyaluronic Acid Synthetic Enzyme Protein' Patent Registered (10-1662990)
  • - KIPO, 'Jelly Fish Green Fluorescent Protein' Patent Registered (10-1661913)
  • - KIPO, 'Green Fluorescent Protein and Human EGF Hybrid Protein' Patent Registered (10-1661912)
  • - KIPO, 'Triple Hybrid Protein' Patent Registered (10-1657297)
  • - KIPO, 'Human EGF and Human Growth Hormone Hybrid Protein' Patent Registered (10-1657299)
  • - KIPO, 'Enhanced Cell Proliferate Human EGF Hybrid Protein' Patent Registered (10-1657298)
  • - Enlarged Manufacturing Plant (1,320㎡)
  • - KIPO, 'Enhanced Anti-Oxidant and Cell Proliferation EGF Hybrid Protein' Patent Registered (10-1652956)
  • - KIPO, 'Increased Heat Stability Human Growth Hormone Hybrid Protein' Patent Registered (10-1652953)
  • - KIPO, 'Spider Toxin Hybrid Protein' Patent Registered (10-1636851)
  • - Grand Prize Winner of the 10th Korean Patent Award (Hankook Ilbo)
  • - 2016 Korean Quality Competitive Award - Bio Technology (Hankook Ilbo)
  • - KIPO, 'SV82 Polypeptide use as Anti-Wrinkle and Elasticity Enhancing Cosmetic Ingredients' Patent registered (10-1613302)

• 2015

  • - Spider Toxin Protein Raw Materials enlisted in INCI
  • - NEXGEN Head Office relocated to Seoul (2F, Building B1,135, Gasan digital 2-ro, Geumcheon-gu, Seoul)
  • - KIPO, 'Green Fluorescent Protein and Human EGF Hybrid Protein' Patent Registered (10-1482187-00-00)

• 2014

  • - Developed and Introduced Preservative-Free, Sterilized, Synthetic Spider Fiber Protein based Serum; ‘Spider Fiber 1’
  • - SBC QA, Quality Management System certified (KS Q ISO 9001 : 2009 / ISO 9001 : 2008)
  • - Awarded the ‘New Technology of the Korean Beauty Industry’ (Hankook Ilbo)

• 2013

  • - Spider Silk Protein, Enlisted in INCI (World's 2nd)

• 2012

  • - Published 1st edition of esthetic magazine ‘THE NEXT’
  • - Opened Gang Nam Office

• 2011

  • - R&D Center applied for Fermentation Refinery LMO Experiment Facility to the Ministry of Education & Science
  • - Recombinant Spider Silk Protein enlisted in INCI
  • - Annexed Research Laboratory Re-Authenticated

• 2009

  • - Achieved Cosmetics Manufacturing License (KFDA Seoul Office)
  • - KIPO, 'Method of Recombinant Protein mass production from transformed Plant adventitious root' Patent Registered (10-0894323)
  • - EGF achieved GH Quality Certification (Korean Health Industry Development Institute)
  • - EGF Rapid Strip Kit achieved GH Quality Certification (Korean Health Industry Development Institute)
  • - Changed the Company Name to Nexgen Biotechnologies, Inc.
  • - KIPO, 'Method of Recombinant Protein Production using the Plant Secretion System' patent registered (10-0891975-00-00)

• 2008

  • - NEXGEN Headquarters moved to Seoul Gasan Digital Complex

• 2005

  • - Awarded as Korea's 10 Best New Technologies of 2005
  • - NEXGEN officially appointed as the National Research Laboratory by the Government
  • - Developed Avian Influenza Diagnostic KIT

• 2001

  • - GMO KIT certified by the US FDA
  • - ISO 9001 Certified
  • - Winner of an Excellent Venture Company in Bio Sector (awarded by the Ministry of Science and Technology)

• 2000

  • - Opened NEXGEN Research Institute and introduced Korea’s first GMO Detection KIT
  • - The GMO KIT was recognized as the 10 Best Korean Business Accomplishments by Popular Science
  • - Awarded as Best Employment Promotion Convention by the Ministry of Labor

• 1999

  • - Incorporated in Daejeon, Republic of Korea